skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 264,260  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: Database: ROAD: Directory of Open Access Scholarly Resources remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Retraction: Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysis
Retraction: Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Retraction: Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysis

Frontiers in oncology, 2024, Vol.14, p.1383346-1383346 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383346 ;PMID: 38440226

Full text available

Citations Cited by
2
Retraction: Meta analysis of clinical prognosis of radiofrequency ablation versus partial nephrectomy in the treatment of early renal cell carcinoma
Retraction: Meta analysis of clinical prognosis of radiofrequency ablation versus partial nephrectomy in the treatment of early renal cell carcinoma
Material Type:
Article 		Add to My Research

Retraction: Meta analysis of clinical prognosis of radiofrequency ablation versus partial nephrectomy in the treatment of early renal cell carcinoma

Frontiers in oncology, 2024, Vol.14, p.1383353-1383353 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383353 ;PMID: 38444681

Full text available

Citations Cited by
3
Retraction: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer
Retraction: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer
Material Type:
Article 		Add to My Research

Retraction: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer

Frontiers in oncology, 2024, Vol.14, p.1383383-1383383 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383383 ;PMID: 38450197

Full text available

Citations Cited by
4
Retraction: Evaluation of the safety of retroperitoneal laparoscopic partial nephrectomy by investigating the perioperative indicators
Retraction: Evaluation of the safety of retroperitoneal laparoscopic partial nephrectomy by investigating the perioperative indicators
Material Type:
Article 		Add to My Research

Retraction: Evaluation of the safety of retroperitoneal laparoscopic partial nephrectomy by investigating the perioperative indicators

Frontiers in oncology, 2024, Vol.14, p.1383340-1383340 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383340 ;PMID: 38440232

Full text available

Citations Cited by
5
Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis
Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis
Material Type:
Article 		Add to My Research

Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis

Frontiers in oncology, 2024, Vol.14, p.1383366-1383366 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383366 ;PMID: 38440228

Full text available

Citations Cited by
6
Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM
Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM
Material Type:
Article 		Add to My Research

Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM

Frontiers in oncology, 2024, Vol.14, p.1399853-1399853 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1399853 ;PMID: 38577339

Full text available

Citations Cited by
7
Retraction: Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progression
Retraction: Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progression
Material Type:
Article 		Add to My Research

Retraction: Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progression

Frontiers in oncology, 2024, Vol.14, p.1388383-1388383 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1388383 ;PMID: 38505586

Full text available

Citations Cited by
8
Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer
Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer
Material Type:
Article 		Add to My Research

Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer

Frontiers in oncology, 2024, Vol.14, p.1383394-1383394 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383394 ;PMID: 38450196

Full text available

Citations Cited by
9
Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis
Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis
Material Type:
Article 		Add to My Research

Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis

Frontiers in oncology, 2024, Vol.14, p.1383410-1383410 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383410 ;PMID: 38444679

Full text available

Citations Cited by
10
Retraction: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma
Retraction: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Retraction: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma

Frontiers in oncology, 2024, Vol.14, p.1383375-1383375 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383375 ;PMID: 38454926

Full text available

Citations Cited by
11
Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin
Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin
Material Type:
Article 		Add to My Research

Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin

Frontiers in oncology, 2023-12, Vol.13, p.1337635-1337635 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1337635 ;PMID: 38130993

Full text available

Citations Cited by
12
Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics
Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics
Material Type:
Article 		Add to My Research

Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics

Frontiers in oncology, 2023-12, Vol.13, p.1343833-1343833 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1343833 ;PMID: 38130994

Full text available

Citations Cited by
13
Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathway
Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathway
Material Type:
Article 		Add to My Research

Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathway

Frontiers in oncology, 2023-12, Vol.13, p.1298859-1298859 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1298859 ;PMID: 38115901

Full text available

Citations Cited by
14
Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
Material Type:
Article 		Add to My Research

Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors

Frontiers in oncology, 2023-10, Vol.13, p.1301668-1301668 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1301668

Full text available

Citations Cited by
15
Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8
Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8
Material Type:
Article 		Add to My Research

Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8

Frontiers in oncology, 2023-10, Vol.13, p.1307324-1307324 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1307324

Full text available

Citations Cited by
16
Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway
Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway
Material Type:
Article 		Add to My Research

Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway

Frontiers in oncology, 2023-10, Vol.13, p.1298871-1298871 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1298871

Full text available

Citations Cited by
17
Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway
Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway
Material Type:
Article 		Add to My Research

Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway

Frontiers in oncology, 2023-09, Vol.13, p.1294881-1294881 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1294881

Full text available

Citations Cited by
18
Retraction: CAR-NK Cell: a new paradigm in tumor immunotherapy
Retraction: CAR-NK Cell: a new paradigm in tumor immunotherapy
Material Type:
Article 		Add to My Research

Retraction: CAR-NK Cell: a new paradigm in tumor immunotherapy

Frontiers in oncology, 2023-09, Vol.13 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1285219

Full text available

Citations Cited by
19
Biological function and research progress of N 6 -methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers
Biological function and research progress of N 6 -methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers
Material Type:
Article 		Add to My Research

Biological function and research progress of N 6 -methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers

Frontiers in oncology, 2023-07, Vol.13, p.1229168 [Peer Reviewed Journal]

Copyright © 2023 Wu, Li, Chen, Fang, Chen and Zheng. ;Copyright © 2023 Wu, Li, Chen, Fang, Chen and Zheng 2023 Wu, Li, Chen, Fang, Chen and Zheng ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1229168 ;PMID: 37546413

Full text available

Citations Cited by
20
Retraction: Long noncoding RNA SNHG1 activates autophagy and promotes cell invasion in bladder cancer
Retraction: Long noncoding RNA SNHG1 activates autophagy and promotes cell invasion in bladder cancer
Material Type:
Article 		Add to My Research

Retraction: Long noncoding RNA SNHG1 activates autophagy and promotes cell invasion in bladder cancer

Frontiers in oncology, 2023-06, Vol.13, p.1228367-1228367 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1228367 ;PMID: 37377910

Full text available

Citations Cited by

Results 1 - 20 of 264,260  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (212,550)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1983  (69)
  2. 1983 To 1992  (264)
  3. 1993 To 2002  (695)
  4. 2003 To 2013  (30,979)
  5. After 2013  (232,244)
  6. More options open sub menu

Subject 

  1. Science & Technology  (245,537)
  2. Oncology  (242,475)
  3. Life Sciences & Biomedicine  (234,895)
  4. Humans  (84,706)
  5. Cancer  (65,154)
  6. Tumors  (50,044)
  7. Female  (44,858)
  8. Patients  (44,217)
  9. Cancer Therapies  (40,081)
  10. Metastasis  (38,791)
  11. Care And Treatment  (38,579)
  12. Chemotherapy  (35,318)
  13. Male  (35,017)
  14. Medical Prognosis  (33,681)
  15. Prognosis  (33,598)
  16. Health Aspects  (33,179)
  17. Middle Aged  (29,502)
  18. Breast Cancer  (28,291)
  19. Original  (25,165)
  20. Gene Expression  (24,517)
  21. More options open sub menu

Language 

  1. English  (260,974)
  2. Japanese  (28,386)
  3. Portuguese  (4,038)
  4. Spanish  (800)
  5. Norwegian  (243)
  6. Chinese  (88)
  7. French  (61)
  8. Russian  (59)
  9. Korean  (58)
  10. Turkish  (33)
  11. German  (30)
  12. Afrikaans  (13)
  13. Italian  (11)
  14. Polish  (6)
  15. Croatian  (4)
  16. Czech  (3)
  17. Swedish  (2)
  18. Catalan  (1)
  19. Bosnian  (1)
  20. Danish  (1)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait